# S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx

> **NCT00268372** · PHASE3 · TERMINATED · sponsor: **SWOG Cancer Research Network** · enrollment: 6 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** docetaxel
- **DRUG:** 5-fluorouracil
- **PROCEDURE:** surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00268372
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** SWOG eliminated its head and neck committee
- **Last updated:** 2012-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00268372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00268372, "S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00268372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*